Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer’s disease
Hui Wang, Yingchun Shang, Enlin Wang, et al.
Progress in Neurobiology (2022) Vol. 214, pp. 102280-102280
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Multi Targeted Therapy for Alzheimer’s Disease by Guanidinium-Modified Calixarene and Cyclodextrin Co-Assembly Loaded with Insulin
Qiyue Zhang, Qiang Wang, Jingxuan Fu, et al.
ACS Nano (2024)
Closed Access | Times Cited: 26
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 8
Caffeic Acid Phenethyl Ester Suppresses Oxidative Stress and Regulates M1/M2 Microglia Polarization via Sirt6/Nrf2 Pathway to Mitigate Cognitive Impairment in Aged Mice following Anesthesia and Surgery
Yue Wang, Ziwen Cai, Gaofeng Zhan, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 714-714
Open Access | Times Cited: 32
An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases
Xuan Wei, Guangshan Huang, Jiyong Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114619-114619
Open Access | Times Cited: 23
The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102545-102545
Closed Access | Times Cited: 10
Exploring Ubiquitin-Specific Proteases as Therapeutic Targets in Glioblastoma
Vijaya Paul Samuel, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155443-155443
Closed Access | Times Cited: 9
lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Stacked CNN-based multichannel attention networks for Alzheimer disease detection
Najmul Hassan, Abu Saleh Musa Miah, Kota Suzuki, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Designing and Synthesis of Novel Fexofenadine‐Derived Hydrazone‐Schiff bases as Potential Urease Inhibitors: In‐Vitro, Molecular Docking and DFT Investigations
Muhammad Ayaz, Aftab Alam, Zainab Zainab, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 8
Closed Access | Times Cited: 8
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 8
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in mice
Jens Stepan, Daniel E. Heinz, Frederik Dethloff, et al.
Science Signaling (2024) Vol. 17, Iss. 834
Closed Access | Times Cited: 6
A comprehensive review of lessons learned from quantum dots in cancer therapy
Javad Mohammadi, Ali Hheidari, Sohrab Sardari, et al.
Biomedical Materials (2024) Vol. 19, Iss. 5, pp. 052004-052004
Closed Access | Times Cited: 6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer’s Disease by modulating Hippo-Wnt signaling crosstalk
Manas Ranjan Sahu, Mir Hilal Ahmad, Amal Chandra Mondal
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1824-1851
Closed Access | Times Cited: 5
The effects of Ganoderma leucocontextum triterpenoids treatment on the D-galactose and aluminum chloride-induced Alzheimer-like pathology in mouse brain
Zhongzhi Qi, Shizhan Deng, Yexin Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118530-118530
Closed Access | Times Cited: 5
CHAC1: a master regulator of oxidative stress and ferroptosis in human diseases and cancers
Jiasen Sun, Hui Ren, Jiawen Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Synthesis of Novel Benzimidazole Analogs for Neurodegenerative Diseases by Targeting Prolyl Oligopeptidase
Abdul Shakoor, Aftab Alam, Mumtaz Ali, et al.
ChemistrySelect (2024) Vol. 9, Iss. 34
Closed Access | Times Cited: 4
D-glucose-conjugated thioureas containing 2-aminopyrimidine as potential multitarget inhibitors for type 2 diabetes mellitus: Synthesis and biological activity study
Nguyễn Đình Thành, Vũ Ngọc Toán, Vũ Minh Trang
Computers in Biology and Medicine (2025) Vol. 186, pp. 109715-109715
Closed Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Predicting amyloid proteins using attention-based long short-term memory
Zhuowen Li
PeerJ Computer Science (2025) Vol. 11, pp. e2660-e2660
Open Access
Dihydropyrimidines Emerge as Promising Dual‐Acting Inhibitors Targeting Acetylcholinesterase and Monoamine Oxidases for Alzheimer's and Other Neurological Disorders
Maria Saleem Khan, Talha Islam, Muhammad Umer Farooq, et al.
ChemistrySelect (2025) Vol. 10, Iss. 6
Closed Access
Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review
Jian Li, Weimin Zhao, Yitong Wang
Metabolic Brain Disease (2025) Vol. 40, Iss. 2
Closed Access
Behavioral and histopathological insights into phenylthiazolyl-1,3,5-triazines: potential antidepressant candidates in a rat model of depression
Aarti Sati, Pynshngainlang Kyllait, Prashant Gahtori, et al.
Journal of Complementary and Integrative Medicine (2025)
Closed Access
Cytokines in age-related eye diseases: pathogenesis and potential targets for innovative therapies
Tingting Zhang, Ming Liu
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Phenylpropanoids of Eleutherococcus senticosus (Rupr. & maxim.) maxim. Alleviate oxidative stress in Alzheimer's disease in vitro and in vivo models by regulating Mst1 and affecting the Nrf2/Sirt3 pathway
Rui Yang, Xin Meng, Wei Zhao, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108347-108347
Closed Access
Page 1 - Next Page

Scroll to top